Omeros (Germany) Top Insiders

3O8 Stock  EUR 9.45  0.48  5.35%   
Omeros employs about 202 people. The company is managed by 12 executives with a total tenure of roughly 472 years, averaging almost 39.0 years of service per executive, having 16.83 employees per reported executive. Examination of Omeros' management performance can provide insight into the company performance.
Nadia Dac  Insider
VP Officer
Debra MT  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.

Omeros Management Team Effectiveness

The company has return on total asset (ROA) of (0.3241) % which means that it has lost $0.3241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.7633) %, meaning that it generated substantial loss on money invested by shareholders. Omeros' management efficiency ratios could be used to measure how well Omeros manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Omeros' Other Current Assets are most likely to increase significantly in the upcoming years. The Omeros' current Total Current Assets is estimated to increase to about 160.3 M, while Total Assets are projected to decrease to roughly 232.3 M.
The Omeros' current Net Income Applicable To Common Shares is estimated to increase to about 57.3 M, while Common Stock Shares Outstanding is projected to decrease to roughly 62.9 M. Omeros owns a total of 70.9 Million outstanding shares. 30% of Omeros outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Omeros in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Omeros, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Omeros Workforce Comparison

Omeros is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 81,048. Omeros adds roughly 202 in number of employees claiming only tiny portion of equities under Health Care industry.

Omeros Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Omeros Price Series Summation is a cross summation of Omeros price series and its benchmark/peer.

Omeros Notable Stakeholders

An Omeros stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Omeros often face trade-offs trying to please all of them. Omeros' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Omeros' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Omeros Management Performance

The success or failure of an entity such as Omeros often depends on how effective the management is. Omeros management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Omeros management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Omeros management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people.

Omeros Workforce Analysis

Traditionally, organizations such as Omeros use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Omeros within its industry.

Omeros Manpower Efficiency

Return on Omeros Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee776.3K
Net Loss Per Executive13.1M
Working Capital Per Employee270.3K
Working Capital Per Executive4.5M

Complementary Tools for Omeros Stock analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine